On the Way to in vitro Platelet Production
Abstract
The severely decreased platelet counts (10-30. 10(3) platelets/muL) frequently observed in patients undergoing chemotherapy, radiation treatment, or organ transplantation are associated with life-threatening increased bleeding risks. To circumvent these risks, platelet transfusion remains the treatment of choice, despite some limitations which include a limited shelf-life, storage-related deterioration, the development of alloantibodies in recipients and the transmission of infectious diseases. A sustained demand has evolved in recent years for controlled blood products, free of infectious, inflammatory, and immune risks. As a consequence, the challenge for blood centers in the near future will be to ensure an adequate supply of blood platelets, which calls for a reassessment of our transfusion models. To meet this challenge, many laboratories are now turning their research efforts toward the in vitro and customized production of blood platelets. In recent years, there has been a major enthusiasm for the cultured platelet production, as illustrated by the number of reviews that have appeared in recent years. The focus of the present review is to critically asses the arguments put forward in support of the culture of platelets for transfusion purposes. In light of this, we will recapitulate the main advances in this quickly evolving field, while noting the technical limitations to overcome to make cultured platelet a transfusional alternative.
Related
- Immature platelet fraction and reticulated platelet parameters as potential indicators of bone-marrow-related platelet production in dogs and cats: A scoping review
- From embryo flushing to in vitro production: global trends in livestock reproductive biotechnology
- Exploring the transcriptomic and metabolomic associations with fetal overgrowth in Holstein cattle derived from in vitro embryo production
- In vitro evaluation of bulk and nanosized cumin (Cuminum cyminum) extract on rumen gas production kinetics, methane and carbon dioxide productions, nutrient degradability, and fermentation end-products
- Production of mung bean protein isolates by isoelectric precipitation and ultrafiltration-diafiltration: impact on the composition, structural and techno-functional properties as well as in vitro digestibility
BibTeX
@article{strasselrisser2026vitro,
title = {{On the Way to in vitro Platelet Production}},
author = {Catherine Strassel-Risser and Christian Gachet and Francois Lanza},
journal = {Frontiers in Medicine},
year = {2026},
month = oct,
doi = {10.3389/fmed.2018.00239},
url = {https://univoak.hal.science/hal-05254715v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - On the Way to in vitro Platelet Production
AU - Catherine Strassel-Risser
AU - Christian Gachet
AU - Francois Lanza
PY - 2026
DA - 2026/10/14
JO - Frontiers in Medicine
DO - 10.3389/fmed.2018.00239
UR - https://univoak.hal.science/hal-05254715v1
AB - The severely decreased platelet counts (10-30. 10(3) platelets/muL) frequently observed in patients undergoing chemotherapy, radiation treatment, or organ transplantation are associated with life-threatening increased bleeding risks. To circumvent these risks, platelet transfusion remains the treatment of choice, despite some limitations which include a limited shelf-life, storage-related deterioration, the development of alloantibodies in recipients and the transmission of infectious diseases. A sustained demand has evolved in recent years for controlled blood products, free of infectious, inflammatory, and immune risks. As a consequence, the challenge for blood centers in the near future will be to ensure an adequate supply of blood platelets, which calls for a reassessment of our transfusion models. To meet this challenge, many laboratories are now turning their research efforts toward the in vitro and customized production of blood platelets. In recent years, there has been a major enthusiasm for the cultured platelet production, as illustrated by the number of reviews that have appeared in recent years. The focus of the present review is to critically asses the arguments put forward in support of the culture of platelets for transfusion purposes. In light of this, we will recapitulate the main advances in this quickly evolving field, while noting the technical limitations to overcome to make cultured platelet a transfusional alternative.
SN - 2296-858X
ER -